Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.1K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

3.6K
The pathophysiology of pneumonia involves the following steps:
3.6K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.1K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia IV: Management01:28

Pneumonia IV: Management

975
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
975
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.8K
Pneumothorax-I01:26

Pneumothorax-I

1.8K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A controlled longitudinal study clarifies the contours of pediatric long COVID.

Pediatric research·2026
Same author

The role of physical examination in the identification of neonates with early-onset sepsis.

Seminars in perinatology·2026
Same author

Correction for Bhavana et al., "A group B <i>Streptococcus</i> indexed transposon mutant library to accelerate genetic research on an important perinatal pathogen".

Microbiology spectrum·2026
Same author

CRISPR interference in a <i>Streptococcus agalactiae</i> multi-locus sequence type 17 strain.

Journal of bacteriology·2026
Same author

Neonatal artificial intelligence and machine learning mortality prediction modeling: A systematic review for risk adjustment in the neonatal intensive care unit.

Seminars in fetal & neonatal medicine·2025
Same author

"Head sparing" fetal growth restriction is not exactly what it sounds like.

Pediatric research·2025
Same journal

Strategies for prevention of intraventricular hemorrhage in the neonatal intensive care unit.

Seminars in fetal & neonatal medicine·2026
Same journal

Introduction.

Seminars in fetal & neonatal medicine·2026
Same journal

Introduction.

Seminars in fetal & neonatal medicine·2026
Same journal

Should inhaled nitric oxide be used for respiratory failure in preterm infants?

Seminars in fetal & neonatal medicine·2026
Same journal

Inhaled nitric oxide in premature infants for respiratory failure: Discussion and consensus.

Seminars in fetal & neonatal medicine·2026
Same journal

Critical thinking in red blood cell transfusion decisions: Donor, product, recipient, and outcomes.

Seminars in fetal & neonatal medicine·2026
See all related articles

Related Experiment Video

Updated: Mar 5, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

Pneumonia.

Thomas A Hooven1, Richard A Polin1

  • 1Columbia University, Department of Pediatrics, Division of Neonatal-Perinatal Medicine, NewYork-Presbyterian Morgan Stanley Children's Hospital, New York, NY, USA.

Seminars in Fetal & Neonatal Medicine
|March 28, 2017
PubMed
Summary
This summary is machine-generated.

Neonatal pneumonia, a serious infection in newborns, can be caused by various pathogens. Treatment focuses on supportive care and targeted antimicrobial therapy, guided by clinical presentation and response.

Keywords:
ImmunityInfectionMultidrug resistancePulmonaryTORCH infectionVentilator-associated pneumonia

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.3K
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

49.2K

Related Experiment Videos

Last Updated: Mar 5, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.3K
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

49.2K

Area of Science:

  • Neonatology
  • Pediatric Infectious Diseases
  • Microbiology

Background:

  • Neonatal pneumonia is a significant cause of morbidity and mortality in newborns.
  • It can arise as an isolated infection or part of a broader infectious syndrome.
  • Pathogens responsible for neonatal pneumonia include bacteria, viruses, fungi, and parasites.

Purpose of the Study:

  • To review the causes, diagnosis, and management of neonatal pneumonia.
  • To highlight the importance of age-specific pathogen identification in differential diagnosis.
  • To emphasize strategies for empiric antimicrobial therapy selection and monitoring.

Main Methods:

  • Literature review of neonatal pneumonia.
  • Analysis of pathogen transmission routes (vertical and postnatal).
  • Correlation of disease onset age with causative agents.

Main Results:

  • Diverse pathogens can cause neonatal pneumonia.
  • Congenital, early-onset, and late-onset pneumonia are associated with distinct microbial profiles.
  • Microbiological testing challenges necessitate data-driven empiric treatment.

Conclusions:

  • Neonatal pneumonia requires prompt diagnosis and management.
  • Antimicrobial therapy selection should be informed by clinical context and patient age.
  • Close monitoring of treatment response is crucial for successful outcomes.